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ABSTRACT
PURPOSE: To investigate the protective effect of pentoxifylline against the lung injury observed after intestinal ischemia (I) followed 
by a period of reperfusion (R). 
METHODS: Twenty-eight male Wistar rats were equally divided into 4 experimental groups and operated under ketamine-xylazine 
anesthesia. (1) Sham: falsely-operated animals; (2) SS+IR: intestinal ischemia was accomplished by clipping the superior mesenteric 
artery during 60 minutes, with an administration of a standard volume of saline solution (SS) 5 min before the end of the ischemia 
period; the clip was then releases or a 120-min period of reperfusion; (3) I+PTX+R: ischemia as above, PTX was administered (25 mg/
kg) and the gut reperfused as above; (4) PTX+I+PTX+R: Five minutes before arterial occlusion PTX was administered; the superior 
mesenteric artery was then clipped for 60 minutes. After 55-min ischemia, an additional dosis of PTX was administered; the clip was 
removed for reperfusion as above. At the 60th min of reperfusion a third dosis of PTX was administered. 
RESULTS: PTX markedly attenuated lung injury as manifested by significant decreases (all P<0.001 as compared with the SS+IR 
group) of pulmonary wet/dry tissue weight ratio, total protein content, myeloperoxidase activity and tumor necrosis factor-alpha. 
Moreover, it was apparent that in the group PTX+I+PTX+R the improvements have been even more significant. 
CONCLUSION: PTX exerted a protective effect on the lung from the injuries caused by intestinal ischemia/reperfusion.
Keywords: Lung Injury. Ischemia. Reperfusion Injury. Oxidative Stress. Pentoxifylline. Rats.
RESUMO
OBJETIVO: Avaliar os efeitos protetores da pentoxifilina (PTX) na lesão pulmonar observada após isquemia (I) seguida de reperfusão 
(R) intestinal. 
MÉTODOS: Vinte e oito ratos machos foram divididos aleatoriamente em quatro grupos experimentais e operados sobre anestesia 
quetamina-xilazina. (1) Sham: animais falsamente operados; (2) SS+IR: isquemia intestinal realizada pelo clampeamento da artéria 
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mesentérica superior durante 60 minutos, com a administração de solução salina (SS) 5 minutos antes do período de isquemia, após 
a retirada do clamp houve a reperfusão por mais 120 minutos; (3) I+PTX+R: isquemia como mencionado anteriormente seguida da 
administração de PTX (25 mg/Kg) 5 minutos antes do final da isquemia (60 minutos) seguida de reperfusão por mais 120 minutos; (4) 
PTX+I+PTX+R: 5 minutos antes da isquemia foi administrado PTX, após 55 minutos de isquemia foi administrado outra dose de PTX 
e a reperfusão mantida por mais 120 minutos, sendo que aos 60 minutos da reperfusão outra dose de PTX foi administrada. 
RESULTADOS: A pentoxifilina reduziu os marcadores de lesão pulmonar (proteínas totais, malondialdeído, atividade da mieloperoxidase 
e fator de necrose tumoral) quando comparada com o grupo não tratado (P<0.001), contudo esta redução foi mais significante no grupo 
PTX+I+PTX+R. 
CONCLUSÃO: A pentoxifilina exerce efeito protetor no pulmão no trauma causado por isquemia/reperfusão intestinal. 
Descritores: Lesão Pulmonar. Isquemia. Traumatismo por Reperfusão. Estresse Oxidativo. Pentoxifilina. Ratos.
Introduction
Regardless the cause, an intestinal ischemia insult is 
a serious and growing clinical problem, with an unacceptable 
mortality rate over 60%1.
Intestinal ischemia and reperfusion (I/R) leads to 
an acute local inflammatory response, resulting in increased 
microvascular permeability. Intestinal I/R is a common medical 
event associated with both clinical and experimental distant organ 
injury. In particular, the lung tissue appears to be susceptible to 
injury resulting from systemic oxidative stress and inflammatory 
mediators activation. Despite decades of research in this area, I/R 
injury remains a clinically challenging problem2-7 and particularly 
susceptible to the damaging effects of increased neutrophil 
activation following intestinal I/R8. Consequently, many cases 
of intestinal I/R progress into shock, multiple organ failure, and 
death9,10.
Acute lung injury (ALI) and acute respiratory distress 
syndrome (ARDS) is a consequence of host response to a variety 
of direct or indirect stimuli leading to pulmonary inflammation. 
Many of the clinical conditions associated with the development 
of acute respiratory failure include periods of ischemia11-13.
Pentoxifylline (PTX), a methylxanthine derivative 
known for many years for its haemorheological properties, has 
proven to be a potent inhibitor of tumor necrosis factor (TNF) 
production14. It has been suggested that PTX can enhance the 
chemotactic response of neutrophils, but may inhibit phagocytosis 
and the superoxide production by neutrophils and monocytes15. It 
has also been shown that this drug has beneficial effects in patients 
with lung ischemia/reperfusion injury16. The potential local effects 
are important for acute lung injury manifestation by inflammatory 
mediators that are blood- and lymph-borne x,y,z, and oxygen-free 
radical activations17,18.
Based on these literature data, herein we put forward 
the hypothesis that the pre-treatment with PTX may reduce lung 
injury in rats submitted to intestinal ischemia/reperfusion. For 
this purpose we used an animal model of intestinal I/R in which a 
superior mesenteric artery occlusion-reperfusion simulates the I/R 
injury that may occur in clinical situations, and investigated the 
effects of PTX on the systemic (pulmonary) repercussions of this 
insult. 
Methods
Surgical procedure and experimental design
All animal procedures were approved by the Institutional 
Research Committee at Federal University of Sao Paulo (1551/09). 
It was designed as an experimental, randomized, controlled study 
with blind assessment to the outcome.
Twenty-eight adult male Wistar rats (n=7 for every 
group; body weights were 270 to 300 g) were fasted overnight 
with free access to water. Anesthesia was induced by a single 
intraperitoneal injection of ketamine (80 mg/kg) plus xylazine (10 
mg/kg), and the abdomen and groin were shaved and washed with 
10% povidone iodine. A PE-50 tubing catheter was inserted in 
the femoral vein for saline or PTX (Pentox®, Farmasa, SP, Brazil) 
solution infusion. PTX was suspended in Ringer lactate solution 
to a concentration of 25 mg/kg as described previously19-26. Upon 
a 2-cm midline laparotomy, the superior mesenteric artery was 
isolated at its origin and occluded with a Bulldog® atraumatic 
microvascular clamp (Harvard Apparatus, MA, USA) during 
60 min. Mesenteric ischemia was confirmed by cessation of the 
mesenteric pulsations and a palish appearance of the intestines. At 
the end of ischemia period the clamp was released and reperfusion 
(during 120 min) was confirmed by restoration of the pulsations 
and the normal gut color. The animals were randomly assigned to 
one of four groups, as follows. Rats of the Sham (falsely operated) 
group were anesthetized and subjected only to laparotomy and 
visceral manipulation. Group SS+I/R: animals subjected to I/R 
and injected with 0.1 ml of saline solution (SS) 5 minutes before 
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reperfusion. Group I+PTX+R: ischemia procedure as above and, 
5 minutes before reperfusion, PTX was administered (25 mg/kg 
in 0.1 ml). Group PTX+I+PTX+R: pre-treatment with PTX 5 
minutes before ischemia, then another PTX dosis 5 minutes before 
the end of ischemia and a final dosis of PTX at the 60th minute of 
the reperfusion period. Body temperature was maintained to 37°C 
(37 ± 0.6oC) with a heating pad.
At the end of experiment the animals were euthanized (T-
61 Euthanasia Solution®, Schering-Plough, SP, Brazil).
Bronchoalveolar lavage (BAL) fluid for protein assay
Upon thoracotomy, bronchoalveolar lavages (BALs) 
were taken by flushing three times the right lung with sterile saline 
via an intratracheal cannula, using a Miniplus 3® peristaltic pump 
(Gilson, WI, USA). The recovery rate was >85%. The collected 
BALs were centrifuged at 300 x g for 4 min at 4ºC and the 
supernatant was used for protein determination by the method of 
Lowry et al.27. 
The upper lobe of right lungs was removed and 
homogenized (Thorton, INPC, SP, Brazil) in PBS for further 
myeloperoxidase (MPO) activity, thiobarbituric reactive 
substances-malondialdehyde (TBARS-MDA) and tumor necrosis 
factor-alpha (TNF-α) measurements. 
Determination of lipid derived oxidation products
The thiobarbituric acid reactive substance-
malondiadehyde (TBARS-MDA) content of lung tissue was 
determined using the method described by Ohkawa et al.28.
Myeloperoxidase (MPO) activity
Homogenates were centrifuged at 15,000 x g for 10 min 
at 4°C. A 100 mL-aliquot of supernatant was mixed with 900 
mL of 50 mmol·L–1 phosphate buffer (pH= 6.0) containing 0.167 
mg·mL–1 of o-dianisidine dihydrochloride and 0.0005% hydrogen 
peroxide. One unit of peroxidase activity is taken as the amount of 
enzyme decomposing 1 mmol of hydrogen peroxide per minute at 
25°C. Decomposition of hydrogen peroxide was calculated from 
the oxidation of o-dianisidine by using an absorption coefficient of 
11.3 mmol·L–1·cm–1 at 460 nm29.
Cytokine assay
Tissue TNF-α content was measured in lung homogenates 
using commercially available, rat-specific enzyme immunoassay 
(ELISA) kits (Quantikine, R&D Systems, MN, USA). Results 
were expressed as pg/mL. Absorbance was determined at 450 nm 
using a microplate reader (Bio-Tek Instruments, VT, USA).
Morphology
The middle lobe of the right lung was fixed in buffered 
formalin. After embedding in paraffin, 4-μm sections of the tissues 
were stained with hematoxylin-eosin (HE) for light microscopy 
coupled to a video camera (Axiolab Standart 2.0 and AxionCam, 
Zeiss, Jena, Germany, respectively). The slides were evaluated 
blindly by an independent consultant histopathologist.
Wet to dry tissue weight ratio
The lower lobe of the right lung was isolated and 
immediately weighed (wet weight) before being dried for 48 h at 
80°C and weighed again (dry weight). The wet/dry weight ratio 
was then calculated. 
Statistical analysis
Statistical analyses were carried out with a SPSS 11.0 
statistical software (SPSS Inc. Software, IL, USA). Data were 
analyzed by 1-way analysis of variance (ANOVA) with a LSD 
post-hoc test to determine comparisons and differences between 
groups, respectively. All values are expressed as mean ± standard 
deviation with P<0.05 being considered significant.
Results
No deaths were recorded throughout the experiment. The 
protein content in BALs (Figure 1) increased in the group SS+IR 
(62.71 ± 4.61 mg/mL), and decreased in the groups treated with 
PTX (I+PTX+R: 50.14 ± 3.93 mg/mL; PTX+I+PTX+R: 36.28 ± 
3.35 mg/mL).
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FIGURE 1 - Protein content in BALs from rats falsely operated (Sham) 
or subjected to mesenteric artery clamping for intestinal ischemia during 
60 min, followed by clamp release for a 120-min period of reperfusion 
(IR). Control IR rats were treated i.v. with 0.1 mL saline solution (group 
SS+IR). Other IR rats were treated with pentoxifylline (PTX): group 
I+PTX+R received i.v. 25 mg/kg of PTX 5 min before starting the 
reperfusion period; the group PTX+I+PTX+R received i.v. three doses 
of PTX: one 5 min before ischemia, a second one 5 min before starting 
reperfusion, and a third one at the 60th min of reperfusion. Data are mean 
± SD. *P<0.001 compared with all other groups.
The lipid peroxidation (TBARS-MDA; Figure 2) was 
significantly higher in the control IR group (SS+IR: 62.14 ± 4.22 
nmol/mg protein) as compared with the I+PTX+R (52.28 ± 2.63 
nmol/mg protein) and the PTX+I+PTX+R (43.42 ± 1.27 nmol/mg 
protein) groups.
FIGURE 2 - Effect of pentoxifylline treatment on lipid-derived oxidation 
products as determined by the levels of thiobarbituric acid reactive 
substance-malondiadehyde (TBARS-MDA) in rat lung homogenates. 
Groups are as in the legend to Figure 1. Data are mean ± SD. *P<0.001 
regarding all other groups.
Myeloperoxidase activity (MPO; Figure 3) was lower 
in the group PTX+I+PTX+R (30.71 ± 2.81 U/mg protein when 
compared with SS+IR (47.43±2.15 U/mg protein) and I+PTX+R 
(40.43 ± 3.21 U/mg protein).
FIGURE 3 - Effect of pentoxifylline treatment on the myeloperoxidase 
(MPO) activity in rat lung homogenates. Groups are as in the legend to 
Figure 1. Data are mean ± SD. *P<0.001 regarding all other groups.
The levels of TNF-alpha (Figure 4) in lung homogenates 
were higher in all groups when compared with those of the Sham 
group. The has been an increase of TNF-alpha levels in the group 
SS+IR (67.14 ± 6.82 ρg/mL), and a reduction in PTX-treated 
groups, I+PTX+R (55.86 ± 2.27 pg/mL) and PTX+I+PTX+R 
(47.57 ± 2.64 pg/mL).
FIGURE 4 - Effect of pentoxifylline treatment on the tumor necrosis 
factor (TNF)-alpha content in rat lung homogenates. Groups are as in the 
legend to Figure 1. Data are mean ± SD. *P<0.001 regarding all other 
groups.
Figure 5 shows typical lung histological features from 
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both normal and sham-operated [Sham] rats. Lungs from the group 
saline solution plus ischemia-reperfusion [SS+IR] showed severe 
changes. As seen, there was a marked leukocyte (neutrophil) 
infiltration; the alveolar, perivascular, and capillary dilation lead 
to alveolar capillaries wall thickening. These parameters in the 
groups I+PTX+R and PTX+I+PTX+R were all significantly 
improved.
Lung weights (W/D ratios) in Sham group (3.62 ± 0.31) 
were not altered after the 120-min experimental period. The SS+IR 
group had a significantly higher ratio (6.16 ± 0.26) than that in the 
Sham group. This parameter significantly decreased in the groups 
I+PTX+R (5.34 ± 0.25) and PTX+I+PTX+R (4.5 ± 0.35) when 
compared with SS+IR.
FIGURE 5 - Histological lung sections of lungs from sham-operated rats 
[Sham] show a normal pulmonary architecture. In the group SS+IR it can 
be seen massive alveolar congestion and neutrophil infiltration. In the 
groups treated with pentoxifylline, ([I+PTX+R] and [PTX+I+PTX+R]) 
the interstitial congestion was minimal, and the leukocyte (neutrophil) 
infiltration was strongly reduced. Hematoxylin and eosin staining. Scale 
bar: 20 µm. (H.E - 200X).
Discussion
Our current study showed that I/R caused acute lung 
injury, as reflected by increases in protein concentration, MDA 
levels and MPO activity in the lung homogenates, W/D ratio, and 
TNF-alpha levels in lung homogenate and gene expression in lung 
tissue.
Multiple factors contribute to I/R-induced inflammatory 
responses, including complement activation, reactive oxygen 
species (ROS), cytokines, and chemokines. The pulmonary 
vascular endothelium is a barrier to prevent fluids and proteins into 
the interstitium of the lung. These inflammatory mediators have 
been demonstrated to disrupt or injure the endothelial lining and 
lead to increased pulmonary vascular permeability which is the 
major feature of acute lung injury30. Neutrophil sequestration and 
transmigration in the lung play an important role in the pathogenesis 
of ALI/ARDS. Many investigators have demonstrated that I/R 
lung injury is neutrophil-dependent31-33. 
Our results corroborate with these results by demonstrate 
the augments of protein concentration, TBARS-MDA and 
MOP activity in the homogenate in lung tissue of group SS+IR 
and reduced by PTX administration (groups I+PTX+R and 
PTX+I+PTX+R).
Intestinal I/R injury causes local damage as well as remote 
organ injury and dysfunction. The pathophysiology of I/R injury 
is complex, the induction of a systemic proinflammatory cytokine 
response is believed to play a major role, and TNF-alpha is among 
the most important contributors34,35. In a elegant study conducted 
by Cámara-Lemarroy et al.36, showed that intestinal I/R-induced 
lung injury was associated with elevated levels of circulating 
serum TNF-alpha, and the treatment of one dose of PTX reduced 
the intensity of injury and the tissue edema. Lung cytokine levels 
are actually determined by the amount of cytokines released from 
a variety of cell populations, including alveolar macrophages, 
endothelial cells, and epithelial cells, and these multiple sources 
mean that reduced neutrophil infiltration of the lungs may not 
directly translate to a decreased level of cytokines in the lung37-39. 
Our studies corroborated with these authors and expanded of the 
result. In our study, the TNF-alpha levels in homogenate lung tissue 
were higher in the saline-treated group (SS+IR) and reduced in the 
group I+PTX+R, but the decreased was more significant in the 
group treated with three doses of pentoxifylline (PTX+I+PTX+R). 
Morphological examination indicate the severe impact 
in the lung tissue submitted to I/R non-treated, by other hand the 
treatment with PTX reduced the lung damage, especially in the 
group treated with three doses of PTX.
Our study demonstrated that pentoxifylline had preventive 
effects and therapeutic potential in I/R-induced lung injury, but 
our results must be considered carefully. The clinical relevance 
of this manuscript refers to the previous use of pentoxifylline 
in situations requiring procedures ischemia with reperfusion to 
reduce or prevent distant organs damage. Therefore, the long-term 
effect of pentoxifylline warrants further investigation.
In conclusion, our study showed that pentoxifylline 
decreased lung edema, ameliorated lung histological change, 
reduced the production of inflammatory mediators, and neutrophils 
in intestinal I/R-induced lung injury. Pentoxifylline has been given 
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safely in previous clinical studies. Therefore, the administration 
of pentoxifylline may be a useful prophylactic or adjunct drug 
therapy for intestinal I/R-induced lung injury.
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